6337-66-2

Upstream product

• 20118-38-1 chalcone-4-carboxylic acid 
• 1081-75-0 1,3-diphenylpropane 
• 113138-08-2 1-(4-(3-phenylpropyl)phenyl)ethan-1-one 

Downstream Products

• 857540-54-6 4-[3-(4-propionyl-phenyl)-propyl]-benzoic acid 
• 201138-62-7 4-{3-[4-(2-methoxycarbonyl-ethyl)-phenyl]-propyl}-benzoic acid methyl ester 
• 2913-24-8 [3.3]paracyclophane 
• 855414-94-7 {4-[3-(4-methoxycarbonyl-cyclohexyl)-propyl]-cyclohexyl}-acetic acid methyl ester 
• 201138-18-3 4-[3-(4-hydroxymethyl-phenyl)-propyl]-phenethyl alcohol 
• 860693-11-4 4-[3-(4-acetyl-phenyl)-propyl]-benzoic acid 
• 1240512-64-4 C₁₄H₁₉NO₂S 
• 1023826-68-7 4-[3-(4-methoxycarbonylmethyl-phenyl)-propyl]-benzoic acid methyl ester 
• 118298-63-8 4'-<3-(4-benzoylphenyl)propyl>2,4,6-triisopropylbenzophenone 
• 118298-66-1 (4-{3-[4-(7-Hydroxy-3,5-diisopropyl-8,8-dimethyl-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)-phenyl]-propyl}-phenyl)-phenyl-methanone 

Relevant academic research and scientific papers

INHIBITORS OF HISTONE DEACETYLASE

The invention provides compoods and methods for treating cell proliferative- diseases. The invention provides new inhibitors of histone deacetylase enzymatic activity, compositions of the compounds comprising the inhibitors and a pharmaceutically acceptable carrier, excipient, or diluent, and methods of using the compounds to inhibit cellular proliferation in vitro and therapeutically.

Inhibitors of histone deacetylase

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.